Summit Trail Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Summit Trail Advisors's ELV Position: Q2 2026 in Review
Summit Trail Advisors increased its Elevance Health (ELV) stake by 26% in Q2 2026, buying an estimated $653K and bringing the position to 8,519 shares worth $3.29M. The position accounts for 0.04% of the portfolio, ranked #320.
Summit Trail Advisors first reported a position in ELV in Q4 2017 and has held it in 19 quarters since. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Summit Trail Advisors held 8,519 shares of Elevance Health worth $3.29M as of Q2 2026.
- Summit Trail Advisors bought 1,761 Elevance Health shares in Q2 2026, an estimated $653K.
- Elevance Health made up 0.04% of Summit Trail Advisors's portfolio in Q2 2026, its #320 holding.
- Summit Trail Advisors first reported a position in Elevance Health in Q4 2017 and has held it in 19 quarters since.
- 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Summit Trail Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.